Macrolide formulations for inhalation and methods of treatment of endobronchial infections

Details for Australian Patent Application No. 2001283491 (hide)

Owner Chiron Corporation

Inventors Shawar, Ribhi M.; Rycman, David M.; Baker, William R.; Huh, Kay K.; Challoner, Peter B

Agent FB Rice

Pub. Number AU-B-2001283491

PCT Pub. Number WO02/03998

Priority 60217032 10.07.00 US

Filing date 10 July 2001

Wipo publication date 21 January 2002

Acceptance publication date 15 February 2007

International Classifications

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/7048 (2006.01)

A61M 11/00 (2006.01) Sprayers

A61M 13/00 (2006.01) Insufflators for therapeutic or disinfectant purposes

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 February 2007 Application Accepted

  Published as AU-B-2001283491

14 June 2007 Standard Patent Sealed

27 November 2008 Alteration of Name

  The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc.

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001283492

2001283490